Related Experiment Video
Updated: Apr 7, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Glomerulomegaly in lupus nephritis: a prognostic marker for renal outcomes
Hironari Hanaoka1, Masataka Kuwana1,2, Tsutomu Takeuchi1
1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Insights
Glomerulomegaly, or enlarged glomeruli, may predict worse kidney outcomes in lupus nephritis (LN). Early detection of enlarged glomeruli in lupus nephritis can indicate a poorer renal prognosis.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Glomerulomegaly, the abnormal enlargement of glomeruli, is linked to progressive chronic kidney disease (CKD).
- Its role in lupus nephritis (LN) prognosis has been understudied.
- This study investigates glomerulomegaly as a prognostic factor in LN renal pathology.
Purpose of the Study:
- To assess glomerulomegaly as a prognostic factor for renal pathology in lupus nephritis.
- To identify baseline predictors of complete renal response (CR) at 3 years.
- To evaluate long-term renal outcomes up to 10 years.
Main Methods:
- Retrospective analysis of patients with class III or IV LN.
- Division into groups based on complete renal response (CR) at 3 years.
- Comparison of baseline clinical and pathological findings, with up to 10-year follow-up.
Main Results:
- Patients without CR showed longer disease duration and higher proteinuria at baseline.
- A higher proportion of patients without CR exhibited enlarged glomeruli (segmentally or minimally affected).
- Patients with enlarged glomeruli had a worse 10-year CR rate; glomerular area correlated with disease duration.
Conclusions:
- Enlarged glomeruli at LN diagnosis may predict poorer renal prognosis.
- Mechanical glomerular injury could impact clinical outcomes in lupus nephritis.
Aim:
Glomerulomegaly refers to the abnormal enlargement of glomeruli and is associated with an increased risk of progressive chronic kidney disease (CKD). However, it has rarely been investigated in lupus nephritis (LN). We therefore assessed glomerulomegaly as a prognostic factor for renal pathology.
Method:
Patients with class III or IV LN were retrospectively recruited and divided into two groups according to complete renal response (CR) at 3 years after the initiation of induction therapy. Baseline clinical and renal pathological findings were compared to identify prognostic factors, and patients were followed for up to 10 years to assess long-term renal outcomes.
Results:
Nineteen patients with and 19 without CR on 3-year follow-up were analyzed. Long-term disease duration and high levels of proteinuria were frequently observed in patients without CR (P = 0.03 and P = 0.01, respectively) at baseline compared to those with CR. On renal pathological analysis, a significantly higher proportion of patients without CR had enlarged glomeruli than those with CR (P = 0.03) in analysis of segmentally or minimally affected glomeruli. On 10-year follow-up, a higher proportion of patients without enlarged glomeruli maintained CR compared to those with enlarged glomeruli (P = 0.004). Further, glomerular area and disease duration were significantly correlated (P = 0.04).
Conclusions:
Enlarged segmentally or minimally affected glomeruli at diagnosis of LN might predict a worse renal prognosis at 3 years after induction therapy. Mechanical glomerular injury might influence clinical outcomes.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nephrotic Syndrome III : Nursing Management
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Chronic Kidney Disease III: Interprofessional Care

